DOCOSANOL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Docosanol, and when can generic versions of Docosanol launch?
Docosanol is a drug marketed by Alembic, Aurobindo Pharma Ltd, P And L, P And L Development, and Taro. and is included in five NDAs.
The generic ingredient in DOCOSANOL is docosanol. There are five drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the docosanol profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Docosanol
A generic version of DOCOSANOL was approved as docosanol by P AND L on November 19th, 2018.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DOCOSANOL?
- What are the global sales for DOCOSANOL?
- What is Average Wholesale Price for DOCOSANOL?
Summary for DOCOSANOL
| US Patents: | 0 |
| Applicants: | 5 |
| NDAs: | 5 |
| Finished Product Suppliers / Packagers: | 39 |
| Raw Ingredient (Bulk) Api Vendors: | 122 |
| Clinical Trials: | 1 |
| Drug Prices: | Drug price information for DOCOSANOL |
| DailyMed Link: | DOCOSANOL at DailyMed |
Recent Clinical Trials for DOCOSANOL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Laboratoire Boreaderme Inc. | Phase 2 |
| Ecogene 21 | Phase 2 |
Anatomical Therapeutic Chemical (ATC) Classes for DOCOSANOL
US Patents and Regulatory Information for DOCOSANOL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alembic | DOCOSANOL | docosanol | CREAM;TOPICAL | 215839-001 | May 3, 2022 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| P And L Development | DOCOSANOL | docosanol | CREAM;TOPICAL | 212385-001 | Oct 7, 2022 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Aurobindo Pharma Ltd | DOCOSANOL | docosanol | CREAM;TOPICAL | 217090-001 | Mar 1, 2024 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| P And L | DOCOSANOL | docosanol | CREAM;TOPICAL | 208754-001 | Nov 19, 2018 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
